Gabapentin Capsule
Product Images NDC 80425-0128

8 FDA label images from Advanced Rx Pharmacy Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Image 0)

Equation (Image 0)
A formula showing the calculation for creatinine clearance (CLCr), which involves age, weight, serum creatinine levels, and a correction factor for female patients. This calculation is relevant to clinical pharmacology but does not contain branding or product-specific information.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of gabapentin, showing a cyclohexane ring bonded to two side chains: one with an amino group (CH2NH2) and another with a carboxyl group (CH2CO2H).*
FDA Label Image

Equation (Image0)

Equation (Image0)
A line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis represents mean pain scores, ranging from 0 to 10. Gabapentin shows a decline in pain score over time, while placebo scores remain relatively stable.*
FDA Label Image

Figure 2 (Image 1)

Figure 2 (Image 1)
A line graph depicting mean pain scores over a 7-week period comparing placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period, showing pain score trends for each treatment group across baseline through week 7.*
FDA Label Image

Figure3 (Image 3)

Figure3 (Image 3)
Bar chart titled 'Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) doses in two studies. Study 1 shows 12% responders for PBO and 29% for GBP 3600 mg. Study 2 shows 14% responders for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance indicated by p-values less than 0.01 and 0.001.*
FDA Label Image

Figure 4 (Image4)

Figure 4 (Image4)
A scatter plot comparing percentage differences by daily dose in milligrams for three studies labeled 'a', 'b', and 'c'. The x-axis represents daily dose (mg) from 600 to 1800, and the y-axis shows difference (%) from 2 to 22. The plot includes data points for each study at various doses, marked with distinct square symbols and corresponding letters.*
FDA Label Image

Label 1 (Lable 1)

Label 1 (Lable 1)
Gabapentin 100 mg capsule label from Advanced Rx Pharmacy of Tennessee, LLC. The label features storage instructions (20-25°C), a lot number (G10060723), expiration date (7/31/2023), and compares to Neurontin with NDC 80425-0128-02. The label includes a QR code and pharmacy information for Nashville, TN.*
FDA Label Image

Label 2 (Lable 2)

Label 2 (Lable 2)
Gabapentin 100 mg capsule label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes dosage strength (100 mg), storage instructions (20-25°C or 68-77°F), lot number, expiration date (3/31/2024), and barcode. It references comparison to Neurontin and displays product identification details including NDC 80425-0128-03.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.